RLYB Rallybio

Insider Sell: Rallybio

05:06 PM EDT, 06/07/2022 (MT Newswires) -- Kush Parmar, 10% Owner, Director, on June 03, 2022, sold 150,000 shares in Rallybio (RLYB) for $1,875,000. Following the Form 4 filing with the SEC, Parmar h

06-08 05:08

12 Health Care Stocks Moving In Friday's Intraday Session

  Gainers Turning Point (NASDAQ:TPTX) shares rose 116.6% to $74.0 during Friday's regular session. As of 13:30 EST, Turning Point's stock is trading at a volume of 22.4 million, which is 3412.5% of i

06-04 02:15

ADAP, SLDP and ZSAN among mid-day movers

Gainers: Turning Point Therapeutics (TPTX) +117%. Energy Focus (EFOI) +40%. Galecto (GLTO) +25%. Adaptimmune (ADAP) +22%. Amylyx Pharmaceuticals (AMLX) +22%. AudioEye (AEYE) +20%. Sprague Resources L

06-04 01:16

Turning Point, Amylyx top healthcare gainers; Novavax, Rallybio lead losers' pack

Gainers: Turning Point Therapeutics (TPTX) +116%. Amylyx Pharmaceuticals (AMLX) +27%. Yumanity Therapeutics (YMTX) +11%. Amarin (AMRN) +9%. Galecto (GLTO) +8%. Losers: Novavax (NVAX) -13%. Rallybio

06-03 22:16

Rallybio Says CFO Fryer to Retire from Company

10:10 AM EDT, 06/02/2022 (MT Newswires) -- Rallybio (RLYB) said Thursday Chief Financial Officer Jeffrey Fryer will retire from the company. Fryer will continue to serve as CFO until a replacement is

06-02 22:12

Rallybio announces Jeffrey Fryer to retire from CFO position

Rallybio (NASDAQ:RLYB) has announced that Jeffrey Fryer, CPA, will retire from his position as CFO. Mr. Fryer will continue to serve as Rallybio's CFO until a new CFO has been appointed and will retir

06-02 20:53

Rallybio Chief Financial Officer Jeffrey Fryer to Retire >RLYB

By Colin Kellaher Rallybio Corp. on Thursday said company co-founder Jeffrey Fryer plans to retire as chief financial officer. Rallybio said Mr. Fryer will remain in the post he has held since Janua

06-02 20:43

Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer

Business Wire 2-Jun-2022 8:30 AM--Company initiates an external search for its next Chief Financial Officer-- Rallybio Corporation (NASDAQ:RLYB), a clinical-stage biotechnology company committed to i

06-02 20:37

Rallybio: Fryer to Continue as Financial Chief Until Successor Appointed

Rallybio: Fryer to Continue as Financial Chief Until Successor Appointed

06-02 20:32

Rallybio: External Search for Fryer Successor Initiated

Rallybio: External Search for Fryer Successor Initiated

06-02 20:31